Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;35(3):1228-1241.
doi: 10.1007/s00330-024-11157-w. Epub 2024 Oct 29.

Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis

Affiliations

Spatial structural abnormality maps associated with cognitive and physical performance in relapsing-remitting multiple sclerosis

Zhizheng Zhuo et al. Eur Radiol. 2025 Mar.

Abstract

Objectives: We aimed to characterize the brain abnormalities that are associated with the cognitive and physical performance of patients with relapsing-remitting multiple sclerosis (RRMS) using a deep learning algorithm.

Materials and methods: Three-dimensional (3D) nnU-Net was employed to calculate a novel spatial abnormality map by T1-weighted images and 281 RRMS patients (Dataset-1, male/female = 101/180, median age [range] = 35.0 [17.0, 65.0] years) were categorized into subtypes. Comparison of clinical and MRI features between RRMS subtypes was conducted by Kruskal-Wallis test. Kaplan-Meier analysis was conducted to investigate disability progression in RRMS subtypes. Additional validation using two other RRMS datasets (Dataset-2, n = 33 and Dataset-3, n = 56) was conducted.

Results: Five RRMS subtypes were identified: (1) a Frontal-I subtype showing preserved cognitive performance and mild physical disability, and low risk of disability worsening; (2) a Frontal-II subtype showing low cognitive scores and severe physical disability with significant brain volume loss, and a high propensity for disability worsening; (3) a temporal-cerebellar subtype demonstrating lowest cognitive scores and severest physical disability among all subtypes but remaining relatively stable during follow-up; (4) an occipital subtype demonstrating similar clinical and imaging characteristics as the Frontal-II subtype, except a large number of relapses at baseline and preserved cognitive performance; and (5) a subcortical subtype showing preserved cognitive performance and low physical disability but a similar prognosis as the occipital and Frontal-II subtypes. Additional validation confirmed the above findings.

Conclusion: Spatial abnormality maps can explain heterogeneity in cognitive and physical performance in RRMS and may contribute to stratified management.

Key points: Question Can a deep learning algorithm characterize the brain abnormalities associated with the cognitive and physical performance of patients with RRMS? Findings Five RRMS subtypes were identified by the algorithm that demonstrated variable cognitive and physical performance. Clinical relevance The spatial abnormality maps derived RRMS subtypes had distinct cognitive and physical performances, which have a potential for individually tailored management.

Keywords: Brain abnormality; Cognition; Deep learning; Disability; Relapsing-remitting multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Yaou Liu. Conflict of interest: The authors of this manuscript declare relationships with the following companies: Philips (G.H.) and Neusoft, Group Ltd (J.W.). F.B. is a consultant for Bayer-Schering, Biogen-Idec, GeNeuro, Ixico, Merck-Serono, Novartis, and Roche. He has received grants, or grants are pending, from the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) initiative, the Biomedical Research Centre at University College London Hospitals, the Dutch MS Society, ECTRIMS–MAGNIMS, EU-H2020, the Dutch Research Council (NWO), the UK MS Society, and the National Institute for Health Research, University College London. He has received payments for the development of educational presentations from Ixico and his institution from Biogen-Idec and Merck. He is on the editorial board of Radiology, Neuroradiology, Multiple Sclerosis Journal, and Neurology. The remaining authors declare no conflicts of interest. Statistics and biometry: Yaou Liu, Frederik Barkhof, and Sven Haller kindly provided statistical advice for this manuscript. Zhizheng Zhuo (one of the authors) has significant statistical expertise. No complex statistical methods were necessary for this paper. Informed consent: Written informed consent was obtained from all subjects (patients) in this study. Ethical approval: Institutional Review Board (Beijing Tiantan Hospital, Capital Medical University) approval was obtained. Study subjects or cohorts overlap: None of the study subjects or cohorts have been previously reported. Methodology: Retrospective Observational Multicenter study

Comment in

References

    1. Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97:742–768 - DOI - PubMed
    1. Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860–871 - DOI - PubMed - PMC
    1. Engelhardt B, Comabella M, Chan A (2022) Multiple sclerosis: Immunopathological heterogeneity and its implications. Eur J Immunol 52:869–881 - DOI - PubMed - PMC
    1. Oh J, Vidal-Jordana A, Montalban X (2018) Multiple sclerosis: clinical aspects. Curr Opin Neurol 31:752–759 - DOI - PubMed
    1. Bar-Or A, Li R (2021) Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol 20:470–483 - DOI - PubMed

MeSH terms

LinkOut - more resources